Actual Medicinal Product (AMP) Ferrograd 325mg modified-release tablets (Teofarma S.r.l.)

Stability Information

(Some stability information inherited from generic)

Stability: Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes: Protect from Moisture. Protect from light. No stability data in MCAs available.
Provenance: This recommendation is based on the products Ferrograd 325mg modified-release tablets (Teofarma S.R.L).
Generic: Ferrous sulfate
Formulation: Ferrous sulfate 325mg modified-release tablets

Ferrous sulfate
- Ferrous sulfate 325mg modified-release tablets
  - Ferrograd 325mg modified-release tablets (Teofarma S.r.l.)